Steris Laboratories, Inc.; Withdrawal of Approval of 55 Abbreviated New Drug Applications

الملخص

The Food and Drug Administration (FDA) is withdrawing approval of 55 abbreviated new drug applications (ANDA's). Steris Laboratories, Inc., notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.